VC  ARCH Venture Partners

http://www.archventure.com





     Office Locations:

8725 West Higgins Road, Suite 290
Chicago, IL 60631
Phone: 773-380-6600
Fax: 773-380-6606

Get all office locations for this firm with a National Database subscription or Silicon Valley Database subscription.
 

Stages:

  • Early
  • Seed


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare

  •  

    Description:

    Arch Venture Partners is a provider of seed and early-stage venture capital for technology firms with a special expertise in co-founding and building technology firms from startup. ARCH invests primarily in companies co-founded with leading scientists and entrepreneurs, concentrating on bringing to market innovations in life sciences, physical sciences, and information technology. ARCH currently manages eight funds totaling nearly $2.0 billion and has invested in the earliest venture capital rounds for more than 150 companies. ARCH Venture Partners became a private venture partnership after separating from its predecessor company, ARCH Development Corporation. Formed in 1986 by the Trustees of the University of Chicago, ARCH Development Corporation was managed by ARCH founding partners. The first fund, ARCH Venture Fund I, was a $9 million fund established in 1989. ARCH announced August 2014 that its eighth venture fund closed with more than $400 million in subscriptions. ARCH Venture Fund VIII exceeded its $250 million subscription target by more than $150 million.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Silicon Valley Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Clinton W. Bybee Co-founder and Managing Director
    Keith L. Crandell Co-Founder and Managing Director
    Kristina Burow Managing Director
    Mark McDonnell Managing Director & CFO
    Paul Thurk Managing Director

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      06/14/2018


      Mindstrong Health


      CA


      $15,000,000


      Series B


      06/08/2018


      Metacrine


      CA


      $65,000,000


      Series C


      06/05/2018


      Cytrellis Biosystems


      MA


      $28,500,000


      Series B


      05/14/2018


      Beam Therapeutics


      MA


      $87,000,000


      Series A


      05/08/2018


      Luna DNA


      CA


      $4,000,000


      Venture


      04/27/2018


      Proniras


      WA


      undisclosed


      


      01/24/2018


      Ultivue


      MA


      $20,000,000


      Series B


      01/05/2018


      Gossamer Bio


      CA


      $100,000,000


      Seed and Series A


      01/03/2018


      Scholar Rock


      MA


      $47,000,000


      Series C


      12/07/2017


      Metacrine


      CA


      $22,000,000


      Series B


      11/30/2017


      Semma Therapeutics


      MA


      $114,000,000


      Series B


      11/14/2017


      ImmusanT


      MA


      $40,000,000


      Series C


      10/02/2017


      KSQ Therapeutics


      MA


      $76,000,000


      


      09/18/2017


      LifeMine Therapeutics


      MA


      $55,000,000


      Series A


      08/17/2017


      UNITY Biotechnology


      CA


      $35,000,000


      Series B


      08/01/2017


      Homology Medicines


      MA


      $83,500,000


      Series B


     

    Portfolio companies include:


      908 Devices
        web link


      Achaogen
        web link


      Acylin Therapeutics
        web link


      Adesto Technologies
        web link


      Adolor
        web link


      AgBiome
        web link


      Agios Pharmaceuticals
        web link


      Agrivida
        web link


      Ahura Scientific
        web link


      Aira.IO
        web link


      Aledade
        web link


      AlfaLight
        web link


      Allozyne
        web link


      Alnylam Pharmaceuticals
        web link


      ApoGen Biotechnologies
        web link


      Arivale
        web link


      Array BioPharma
        web link


      Aviron
        web link


      Beam Therapeutics
        web link


      BIND Biosciences
        web link


      BlackThorn Therapeutics
        web link


      bluebird bio
        web link


      Boragen


      Boreal Genomics
        web link


      Caliper Life Sciences
        web link


      Callisto Software
        web link


      Cambrios Technologies
        web link


      CEPTYR
        web link


      Chiasma
        web link


      Codiak Biosciences
        web link


      CoolEdge Lighting
        web link


      Cytrellis Biosystems
        web link


      decode Genetics
        web link


      Denali Therapeutics
        web link


      eGenesis
        web link


      Eichrom Technologies
        web link


      EKOS
        web link


      Ensemble Therapeutics
        web link


      Fate Therapeutics
        web link


      Gossamer Bio
        web link


      GPC-Rx
        web link


      Grail
        web link


      Homology Medicines
        web link


      Ikaria
        web link


      Illumina
        web link


      ImmusanT
        web link


      Impinj
        web link


      ImproveNet
        web link


      Intelligent Reasoning Systems
        web link


      ISB Accelerator
        web link


      Juno Therapeutics
        web link


      Just Biotherapeutics
        web link


      Kotura
        web link


      KSQ Therapeutics
        web link


      LifeMine Therapeutics
        web link


      Lodo Therapeutics
        web link


      Luna DNA
        web link


      Lycera
        web link


      MedVantx
        web link


      Metacrine
        web link


      Mindstrong Health
        web link


      Mirina
        web link


      Movidius
        web link


      Nanophase Technologies
        web link


      NearMe
        web link


      NetBot
        web link


      NeurogesX
        web link


      NextCODE Health
        web link


      Nioptics
        web link


      OncoResponse
        web link


      Permeon Biologics
        web link


      PhaseRx
        web link


      PixelEXX Systems
        web link


      Plectix BioSystems
        web link


      Proniras
        web link


      Pulmatrix
        web link


      Quanterix
        web link


      SAGE Therapeutics
        web link


      Scholar Rock
        web link


      Semma Therapeutics
        web link


      Semprius
        web link


      Shocking Technologies
        web link


      Sienna Biopharmaceuticals
        web link


      Siluria Technologies
        web link


      Sorbent Therapeutics
        web link


      Syros Pharmaceuticals
        web link


      Theraclone Sciences
        web link


      Therus


      Twist Bioscience
        web link


      Ultivue
        web link


      UNITY Biotechnology
        web link


      VBI Vaccines
        web link


      VentiRx Pharmaceuticals
        web link


      Vir Biotechnology
        web link


      VLS
        web link


      VLST
        web link


      Voxel8
        web link


      XORI
        web link


      Xtera Communications


     

    Recent News: